Alopecia Areata Trial, Recruiting NCT06560385 Sponsor: GenieBiome Limited Condition: Alopecia Areata
Back to Alopecia Areata

Alopecia Areata Trial, Recruiting

NCT06560385
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 18 and 60 years old who has recently been diagnosed with stage I, II, or III breast cancer
  • You are planned to receive chemotherapy containing a specific type of drug (called an anthracycline or taxane), and this treatment will be finished within 6 months
  • You are mentally able to understand and agree to take part in the study

Who may not be able to join:

  • You already have a type of hair thinning or hair loss (female-pattern baldness) that is at a certain level of severity before the study begins (confirm with trial site)
  • You have had a hair transplant in the past, or you have psoriasis, or you have had a serious scalp infection
  • You are currently using, or plan to use, a scalp cooling treatment (a method sometimes used to reduce hair loss during chemotherapy)
  • You are planned to receive immunotherapy as part of your cancer treatment
  • You are pregnant or currently breastfeeding
  • You have serious problems with your heart, liver, kidneys, lungs, or blood, or any other life-threatening health condition
  • You have taken antibiotics, probiotics, or prebiotics in the month before joining the study
  • You are using any other alternative or complementary treatments for your cancer that could affect gut bacteria analysis (confirm with trial site)
  • You have a known allergy to probiotics or lactose
  • You have previously received chemotherapy for any other condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jessica Ching, PhD, GenieBiome Limited

Phone: 97405209

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
GenieBiome Limited
Registry
ClinicalTrials.gov
Start date
11 September 2024
Est. completion
18 August 2025

Where this trial is recruiting

Hong Kong

Primary endpoints

The proportion of subjects with a score of ≤ 2 on the Dean scale (corresponding to hair loss ≤ 50%) 2 months after the final dose of chemotherapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov